The Micra leadless pacemaker made by Medtronic (NYSE:MDT) showed a high implant success rate and low rates of major complications in a post-approval registry study released today at the annual Hearth Rhythm Society conference in Chicago. The study followed 795 patients implanted with the Micra device, which won FDA approval in April 2016. The safety endpoint was system- […]
hrs2017
HRS 2017: Two-year registry data on Boston Scientific’s S-ICD
Data from a long-term post-approval registry study of the S-ICD subcutaneous pacemaker made by Boston Scientific (NYSE:BSX) showed high successful implantation rates and “acceptable” short-term complication rates, researchers said today at the annual Heart Rhythm Society conference in Chicago. The study looked at data from 1,637 S-ICD patients who met the criteria for implantable cardioverter defibrillator implantation, […]